首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of hepatology

缩写:J HEPATOL

ISSN:0168-8278

e-ISSN:1600-0641

IF/分区:33.0/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引7155
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Qiangnu Zhang,Teng Wei,Wen Jin et al. Qiangnu Zhang et al.
Background & aims: The role of solute carrier family 25 member 15 (SLC25A15), a critical component of the urea cycle, in hepatocellular carcinoma (HCC) progression remains poorly understood. This study investigated the im...
Zhigang Lei,Jiaojiao Yu,Yu Wu et al. Zhigang Lei et al.
Background & aims: Hepatocyte apoptosis, a well-defined form of cell death in non-alcoholic steatohepatitis (NASH), is considered the primary cause of liver inflammation and fibrosis. However, the mechanisms underlying th...
Katrine Holtz Thorhauge,Georg Semmler,Stine Johansen et al. Katrine Holtz Thorhauge et al.
Background & aims: Liver stiffness measurement (LSM) is recommended for disease prognostication and monitoring. We evaluated if LSM, using transient elastography, and LSM changes predict decompensation and mortality in pa...
Yan Yang,Jiale Wang,Jianhua Wan et al. Yan Yang et al.
Background & aims: The PTEN-AKT pathway is frequently altered in extrahepatic cholangiocarcinoma (eCCA). We aimed to evaluate the role of PTEN in the pathogenesis of eCCA and identify novel therapeutic targets for this di...
Rosa Martin-Mateos,Laura Martínez-Arenas,Ángela Carvalho-Gomes et al. Rosa Martin-Mateos et al.
Background & aims: Infections by multidrug-resistant bacteria (MDRB) are an increasing healthcare problem worldwide. This study analyzes the incidence, burden, and risk factors associated with MDRB infections after liver ...
Balakrishnan Chakrapani Narmada,Atefeh Khakpoor,Niranjan Shirgaonkar et al. Balakrishnan Chakrapani Narmada et al.
Background & aims: Hepatitis B surface antigen (HBsAg) loss or functional cure (FC) is considered the optimal therapeutic outcome for patients with chronic hepatitis B (CHB). However, the immune-pathological biomarkers an...